C25 — Malignant neoplasm of pancreas

Not billable

Is C25 billable?

No — C25 is a non-billable header code. C25 groups more specific codes and cannot be submitted on a claim. A valid ICD-10-CM code must be reported at the highest level of specificity available in its branch. Select one of the 8 billable codes beneath C25.

Billable codes under this header

C25 at a glance

Code	C25
Description	Malignant neoplasm of pancreas
Billable	No — header code
Code set	ICD-10-CM FY2027
Valid for encounters	October 1, 2026 – September 30, 2027

Use additional code

Report an additional code alongside C25 to fully describe the condition. C25 is sequenced first.

code to identify:
alcohol abuse and dependence (F10.-)

Code also

Two codes may be needed to describe the condition fully. Whether C25 is sequenced first depends on the reason for the encounter.

if applicable exocrine pancreatic insufficiency (K86.81)

Excludes1 — never code together — inherited from C15-C26

The conditions below can never be reported together with C25 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

Kaposi's sarcoma of gastrointestinal sites (C46.4)

Excludes2 — not included here — inherited from C15-C26

The conditions below are not part of C25, but a patient may have both at the same time. When documentation supports it, C25 and the excluded code may both be reported.

gastrointestinal stromal tumors (C49.A-)

What codes fall under C25? (8)

How long has C25 existed?

C25 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.